183 related articles for article (PubMed ID: 34632621)
21. Diffuse Neonatal Hemangiomatosis: report of 5 cases.
Wananukul S; Voramethkul W; Nuchprayoon I; Seksarn P
J Med Assoc Thai; 2006 Aug; 89(8):1297-303. PubMed ID: 17048444
[TBL] [Abstract][Full Text] [Related]
22. Diffuse neonatal hemangiomatosis in a very low-birthweight infant treated with erythropoietin.
Okuno T; Tokuriki S; Yoshino T; Tanaka N; Ohshima Y
Pediatr Int; 2015 Apr; 57(2):e34-6. PubMed ID: 25868957
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
[TBL] [Abstract][Full Text] [Related]
24. Benign neonatal hemangiomatosis in a pre-term infant.
Von Bubnoff D; Bieber T; Steen K
J Dermatol; 2002 Aug; 29(8):533-5. PubMed ID: 12227490
[TBL] [Abstract][Full Text] [Related]
25. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
26. Propranolol for infantile hemangiomas with hyperinsulinemic hypoglycemia.
Miyazaki T; Ozeki M; Sasai H; Ohnishi H
Pediatr Int; 2021 Jun; 63(6):724-725. PubMed ID: 34042227
[No Abstract] [Full Text] [Related]
27. Benign neonatal hemangiomatosis with early regression of skin lesions: A case report and review of the published work.
Korekawa A; Nakajima K; Nakano H; Sawamura D
J Dermatol; 2020 Aug; 47(8):911-916. PubMed ID: 32490542
[TBL] [Abstract][Full Text] [Related]
28. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
29. MRI of disseminated neonatal hemangiomatosis: case report.
Montgomery SP; Guillot AP; Barth RA
Pediatr Radiol; 1990; 20(3):204-5. PubMed ID: 2352803
[TBL] [Abstract][Full Text] [Related]
30. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
31. Histopathology of the eye in diffuse neonatal hemangiomatosis.
Chang CW; Rao NA; Stout JT
Am J Ophthalmol; 1998 Jun; 125(6):868-70. PubMed ID: 9645726
[TBL] [Abstract][Full Text] [Related]
32. Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development.
Moyakine AV; Hermans DJ; Fuijkschot J; van der Vleuten CJ
J Am Acad Dermatol; 2015 Aug; 73(2):341-2. PubMed ID: 26183988
[No Abstract] [Full Text] [Related]
33. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Clinical Properties and Treatment Responses of Infantile Hemangioma.
Yildirimcakar D; Demirsoy U; Azizoglu M; Corapcioglu F
J Drugs Dermatol; 2020 Dec; 19(12):1156-1165. PubMed ID: 33346523
[TBL] [Abstract][Full Text] [Related]
35. [What's new about infantile hemangiomas?].
Dreyfus I; Maza A; Mazereeuw-Hautier J
Arch Pediatr; 2013 Jul; 20(7):809-16. PubMed ID: 23628116
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a modified outpatient model for using propranolol to treat infantile hemangiomas.
Putterman E; Wan J; Streicher JL; Yan AC
Pediatr Dermatol; 2019 Jul; 36(4):471-476. PubMed ID: 31120143
[TBL] [Abstract][Full Text] [Related]
37. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
38. [Rare presentations of infantile hemangiomas: 4 cases].
Babic V; Schoeffler A; Moawad S; Mainard L; Schmutz JL; Bursztejn AC
Ann Dermatol Venereol; 2018 Dec; 145(12):749-755. PubMed ID: 30415930
[TBL] [Abstract][Full Text] [Related]
39. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.
Xiao Q; Li Q; Zhang B; Yu W
Pediatr Surg Int; 2013 Jun; 29(6):575-81. PubMed ID: 23519547
[TBL] [Abstract][Full Text] [Related]
40. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers.
Martin K; Blei F; Chamlin SL; Chiu YE; Frieden IJ; Frommelt PC; Garzon MC; Kwon EK; MacLellan-Tobert S; Mancini AJ; Seefeldt M; Sidbury R; Siegel DH; Drolet BA; Boucek RJ
Pediatr Dermatol; 2013; 30(1):155-9. PubMed ID: 23316721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
